Diatrizoate Meglumine and Diatrizoate Sodium 660 mg/mL

Diatrizoate Meglumine and Diatrizoate Sodium 660 mg/mL is a radiopaque contrast agent used for diagnostic imaging procedures. This solution aids in enhancing visibility during X-rays and other imaging techniques.

Diatrizoate Meglumine and Diatrizoate Sodium 660 mg/mL is primarily used as a contrast medium to improve the visibility of internal structures during radiographic imaging. It is commonly administered orally or rectally to facilitate the examination of the gastrointestinal tract. This solution helps in identifying abnormalities and providing clear images for diagnostic purposes.

Common effects of Diatrizoate Meglumine and Diatrizoate Sodium 660 mg/mL may include a temporary sensation of warmth or flushing. Some individuals might experience mild nausea or a metallic taste in the mouth. These effects are generally short-lived and subside quickly.

Handle Diatrizoate Meglumine and Diatrizoate Sodium 660 mg/mL with care, ensuring it is stored at the recommended temperature. Always follow the instructions provided by healthcare professionals for safe administration. Avoid contact with eyes and skin, and wash hands thoroughly after handling.

Diatrizoate Meglumine and Diatrizoate Sodium 660 mg/mL may interact with certain medications, including other contrast agents and some types of diuretics. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol consumption should be avoided before and after administration.